Skip to main content

b 213 750 (Niacin Extended-Release 750 mg)

Pill with imprint b 213 750 is White, Capsule-shape and has been identified as Niacin Extended-Release 750 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Niacin is used in the treatment of high cholesterol; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia; niacin deficiency; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug classes miscellaneous antihyperlipidemic agents, vitamins. Risk cannot be ruled out during pregnancy. Niacin 750 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for b 213 750

Niacin Extended-Release

Imprint
b 213 750
Strength
750 mg
Color
White
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Miscellaneous antihyperlipidemic agents, Vitamins
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-7393 (Discontinued)
Inactive Ingredients
povidone k90, stearic acid

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.